$name

The accelerated evolution of life sciences commercial models

Discover how the COVID-19 pandemic accelerated the already emerging themes in the commercial landscape.

How has the industry responded across various countries?

Learn how pharmaceutical markets across different countries and regions have responded differently to the COVID-19 pandemic.

What is the current commercial reality for the industry?

Life sciences companies now have a clearer understanding on what their sales engagement and commercial activities should look like. How are you embracing the current reality?

What does the future hold for your team?

As the promotional landscape continues to evolve, find out what the future will hold for field based teams and why flexibility will be fundamental

Is there more value in commercial outsourcing partnerships?

Commercial outsourcing companies have seized the opportunity to prove their value and the support they can provide when working in partnership — find out how.

What to expect from successful commercial outsourcing companies over the next 5 years

Industry models and the role of external outsourcing companies are changing. So, what can you expect to see in 5 years’ time?

The industry can play a key part in improving HCP and patient engagement

Explore the common trends that are beginning to emerge and how they can be utilised to improve HCP and patient engagement.

Is there an opportunity for the industry to change the optic?

The industry has recently demonstrated its true value. Can this be leveraged to change previous perceptions and provide more scope to support health systems?

A greater focus on team skills and capabilities is necessary

Engagement models are changing, but it is not solely the modes of interaction. Find out why it is fundamental for life sciences companies to increase the focus on their teams’ skillsets.